Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

MRC and Wellcome Trust Invest £24m in Cambridge Obesity Institute

Published: Thursday, May 30, 2013
Last Updated: Thursday, May 30, 2013
Bookmark and Share
The joint venture provides a unique environment linking basic and applied science in metabolic diseases.

The Institute houses not only state-of-the-art facilities for laboratory science, clinical and population research, but also purpose-built clinics providing out-patient care for children and adults with metabolic and endocrine disorders.

This close link to patients ensures that advances in basic science can be applied rapidly to improving patient care and disease prevention. The IMS is also close to the largest concentration of biotechnology companies in Europe, creating excellent opportunities for industrial collaboration.

Funding from the MRC will establish a new MRC Metabolic Diseases Unit (MDU) at the IMS, under the direction of Professor O’Rahilly, as well as new programmes of research at the existing MRC Epidemiology Unit and MRC Human Nutrition Research. The Wellcome Trust investment will create an enhanced Clinical Research Facility dedicated to metabolic studies, as well as providing funding for major core laboratory equipment and studies in animal models.

Stephen O’Rahilly, Co-Director of the Wellcome Trust-MRC IMS and Director of the MRC MDU, University of Cambridge, said:

“This joint initiative from the MRC and Wellcome Trust will provide exciting new opportunities to better understand the fundamental causes of disease such as obesity and diabetes and translate that knowledge into improved therapies.”

Professor Sir John Savill, Chief Executive of the MRC, said:

“Obesity is one of the biggest challenges facing the future health of the developed world and understanding the causes and consequences of this condition are major research priority. The MRC is very happy to be partnering with the Wellcome Trust and University of Cambridge in an ambitious joint venture that will unite experts in basic science, population science and experimental medicine to create a world-leading centre for metabolic research.”

Dr Ted Bianco, Acting Director of the Wellcome Trust, said:

“With obesity rates soaring across the globe, the need to understand the biological, behavioural and environmental factors that influence metabolic diseases has never been greater. This additional investment from us and the MRC reflects the quality of research that is being undertaken at Cambridge and lays the foundations for taking basic scientific discoveries right through to clinical advances.”

Professor Sir Leszek Borysiewicz, Vice-Chancellor of the University of Cambridge, said:
“Obesity has become an urgent public health issue as research continues to reveal its detrimental effects. With obesity doubling between 1980 and 2008 – a span of less than 30 years – investing in obesity research has never been more critical, and the University is delighted with the support of the MRC and the Wellcome Trust.”

The £24m joint investment will be broken down as follows:

o    £10.8m from the MRC to establish a new university unit: the MRC Metabolic Diseases Unit, University of Cambridge (Directed by Professor Steve O’Rahilly and located at the Wellcome Trust-MRC IMS).
o    £10.1m from the Wellcome Trust for basic science infrastructure and new clinical research facilities at the IMS, and to support joint working with the Sanger Institute.
o    £2.5m from the MRC for research into biomarkers for diabetes at the MRC Epidemiology Unit, University of Cambridge (Directed by Professor Nick Wareham and located at the Wellcome Trust-MRC IMS).
o    £1m from the MRC for a collaborative programme to investigate human fat metabolism led by MRC Human Nutrition Research (Directed by Professor Ann Prentice and based at the Elsie Widdowson Laboratory in Cambridge).

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Institute to Study Obesity, Diabetes and Other Metabolic Disorders
A new centre has opened to address the growing threat to public health posed by obesity, diabetes and related diseases. The University of Cambridge, the Medical Research Council and Cambridge University Hospitals NHS Foundation Trust have joined forces to create the unique, innovative Institute of Metabolic Science (IMS).
Friday, August 29, 2008
Scientific News
How it Works: Advanced Data Analysis Using Visualization
Visualisation of data can be used to help molecular biologists tackle the vast datasets their experiments create.
Cell Metabolism Linked to Spread of Cancer
Scientists discover macrophage metabolism can be attuned to prevent the spread of cancer.
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Fatty Liver Disease Linked to Type 2 Diabetes
Recent study identifies factors causing insulin to misbehave in non-alcoholic fatty liver disease.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Lab-on-a-Chip Detects Effects of Poison
A fast and efficient mixer has been developed for testing the effect of toxic substances faster by using a new lab-on-a-chip.
Clinical Trial Finds Medicine Program Alters Blood Serum
Meditation, yoga and vegetarian diet linked to decline in plasma metabolites associated with inflammation and cardiovascular disease risk.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Targeting Cardiovascular Disease Risk Factors May be Important Across a Lifetime
The study suggests efforts to prevent risk factors should extend to those older than 65.
Beige Fat Formation Linked to Anti-diabetic Effect
Researchers at UTSW have found that the protein connexin 43 forms cell-to-cell communication channels on the surface of emerging beige fat cells that amplify the signals from those few nerve fibers.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos